51. Inhibition of the hemolytic activity caused by Staphylococcus aureus alpha-hemolysin through isatin-Schiff copper(II) complexes.
- Author
-
Melo MC, Teixeira LR, Pol-Fachin L, and Rodrigues CG
- Subjects
- Animals, Antitoxins chemistry, Bacterial Toxins chemistry, Bacterial Toxins metabolism, Copper chemistry, Hemolysin Proteins chemistry, Hemolysin Proteins metabolism, Hemolysis, Isatin chemistry, Molecular Docking Simulation, Rabbits, Schiff Bases chemistry, Antitoxins metabolism, Bacterial Toxins antagonists & inhibitors, Copper metabolism, Erythrocytes drug effects, Hemolysin Proteins antagonists & inhibitors, Isatin metabolism, Schiff Bases metabolism, Staphylococcus aureus metabolism
- Abstract
A great number of pathogens secrete pore-forming proteins during infection. Such molecules, from either bacterial or viral origin, are considered important virulence factors, which makes them attractive targets in the study of new therapeutic agents. Thus, the inhibitory activity of isatin-Schiff base copper(II) complexes was evaluated against membrane damage activity of Staphylococcus aureus α-hemolysin (α-HL). For this purpose, a standard hemolysis assay with rabbit erythrocytes and micromolar concentrations of the compounds was employed. Additionally, planar artificial lipid membranes with a single α-HL ion channel and molecular docking studies were used to elucidate the molecular mechanism of the complexes. Accordingly, the compounds were observed to possess a significant anti-hemolytic activity, capable of interacting with the constriction region of α-HL channel and blocking it in a potential dependent manner. Based on these results, it is expected that such isatin-Schiff base Copper(II) complexes may be employed as cotherapeutic agents for the treatment of staphylococcal infections., (© FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF